# Source:Dr. John Campbell, URL:https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg, language:en-UK

## Live lesson with Tanzania
 - [https://www.youtube.com/watch?v=jGpit7vMSoA](https://www.youtube.com/watch?v=jGpit7vMSoA)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg
 - date published: 2020-12-16 00:00:00+00:00

Tanzania, Live Q and A

With Doctor Nasibu Mwande

John’s introduction 0 – 10 minutes

Do mRNA vaccines effect human DNA? 10 mins

Does the vaccine confer immunity on all ethnic groups? 12 mins

Will mRNA vaccines cause human mutations? 16 mins

Do vaccines carry a secret code that can track people? 22 mins

Did the UK authorise the Oxford vaccine too quickly? 26 mins

Is the vaccine safe for children? 32 mins

What about the dose for the Oxford vaccine? 45 mins

What is the dose for vitamin D? 53 mins

## Update, Wed 16 Dec
 - [https://www.youtube.com/watch?v=wb_0FB7XiqA](https://www.youtube.com/watch?v=wb_0FB7XiqA)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg
 - date published: 2020-12-16 00:00:00+00:00

UK 

Christmas rules

Germany

Deaths, + 935

Schools

Non-essential businesses

until 10 January

One household, four close family members

France

Curfew

Bars and restaurants closed until 20 January

Spain

https://www.theguardian.com/world/live/2020/dec/15/coronavirus-live-news-netherlands-announces-five-week-lockdown-as-uk-detects-new-covid-strain

10% antibody study shows

N = 51,400

Second half of November

Raquel Yotti, Carlos III health institute

One in 10 people living in Spain would have been infected ... half during the first wave and the other half during this second epidemic wave

Madrid, 18.6% 

Previous results of the study - published in July after testing nearly 70,000 people in 

April-June, prevalence 5.2 %.

Deaths, + 388 = 48,401

Positive test results, + 10,328 = 1,762,212

Population = 47 million

Cases, 4.7 million

CFR = 2.7%

IFR = 1.02%

Moderna / NIH

Food and Drug Administration scientists

https://www.fda.gov/media/144434/download

54 page document

Two-shot regimen was highly effective, 94%

Prevents infections and symptoms

No serious safety concerns

Friday, 18th 

General Gustave Perna

Cambridge, Massachusetts, "vast majority" 

Preparing to ship almost 6 million doses

3,285 locations in the first week

US, 20 million then 200 million

It will be a very similar cadence that was executed this week with Pfizer, where we’re hitting initial sites on Monday, follow on Tuesday and Wednesday

Canada, 168,000 this year, 56 million by March

UK, 7 million

European Union, 80m + 80m

Japan, 50m

South Korea, 20m

Switzerland, 7.5m

Vaccine progress

MHRA, 1

137,000 in first week

FDA, 2

HC, 1

EMA, 0

Second peer reviewed vaccine study

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=featured_home

Ongoing multinational

Placebo-controlled, observer-blinded, randomised, efficacy trial

16 years or older

One to one

Two doses, 21 days apart

Placebo or the BNT162b2 vaccine

30 μg per dose

Lipid nanoparticle

Modified RNA vaccine

Encodes a membrane-anchored SARS-CoV-2 full-length spike protein

n = 43,448 received injections

BNT162b2 group, n = 21,720

8 cases of COVID, at least 7 days after the second dose

1 severe

Placebo group, n = 21,782

162 cases

9 severe

95% (90.3 to 97.6)

October 9

N = 37,706 with at least 2 months of safety data

49% were female, 

83% were white, 

9% were Black or African American, 

28% were Hispanic or Latino 

35% were obese, of at least 30.0

21% had at least one coexisting condition

Median age, 52 years

42% older than 55 years

Safety profile

Short-term, mild-to-moderate pain at the injection site, fatigue, and headache

Safety over a median of 2 months was similar to that of other viral vaccines. 

Systemic events, most common after 2nd dose

Resolved after 1 – 2 days

Fatigue and headache, 55%

Placebo fatigue and headache, 23%
 
Fever, mostly after 2nd dose

Temperature, equal or greater than 38°C

16% of younger recipients

11% of older recipients

Incidence of serious adverse events was low and was similar in the vaccine and placebo groups

No stopping rules were met

## Pandemic, Tuesday 15 Dec
 - [https://www.youtube.com/watch?v=c38i4_4o1DI](https://www.youtube.com/watch?v=c38i4_4o1DI)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg
 - date published: 2020-12-15 00:00:00+00:00

campbellteaching@hotmail.com for pictures of the pandemic please
UK, Official data

https://coronavirus.data.gov.uk/details/cases

London

Cases, + 4,710 (10th December)

Up 93% in 7 days

Increases in all age groups

From 00:01 GMT, Wednesday, Tier 3

Cannot mix indoors, in private gardens or in most outdoor venues,

except with your household or bubble

You can meet in a group of up to six in other outdoor spaces

Shops, gyms and personal care services (such as hairdressing) can stay open

Bars, pubs, cafes and restaurants must stay closed, except for delivery and takeaway

No sports in stadiums

Indoor entertainment venues, closed

Advised not to travel to and from tier three areas

United States, CDC trends (Tuesday 15th December)

https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases

Thanksgiving surge, peak now

Cases, + 193,384 = 16,339,404

Cases up 10.1% in past 7 days

Tests, + 2,159,487 = 221,100,799

Testing up 6.3% in past 7 days

Currently hospitalized, 110,549 (21,456) (7,706)

Official US hospitalizations

https://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html

Deaths, 300, 500

Cases per 100,000 (up to 12th December)

https://covidtracking.com

Asian,   1,575  (21)

Black / AA,  3,941  (94 )

Hispanic / L,  4, 656 %  (44)

White,   2,735  (63)

Pfizer-BioNTech COVID-19 vaccine, White House waived preferential vaccination

Mr Trump 

not scheduled to take the vaccine, but look forward to doing so at the appropriate time

Vaccination cards, issued by health officials

European Medicines Agency (EMA)

Pfizer/BioNTech Covid vaccine, December 23rd

Moderna vaccine by mid-January

Germany, ready to vaccinate

Has created 400 vaccination centres

Activated 10,000 medical staff 

Simply not allowed


UK

Oxford AZ Vaccine

Four million does ready to go

https://www.google.com/search?client=safari&rls=en&q=genomics+england&ie=UTF-8&oe=UTF-8

Company set up and owned by the Department of Health and Social Care,

to run the 100,000 Genomes Project

Infectious diseases division

Selection pressures will increase with increasing vaccination

1,000 cases

South East

Double deletion at H69 / 70 (similar to Mink mutation)

N50, receptor-binding domain

Seems more prevalent where cases are increasing

From Wuhan to now, 25 mutations

Vaccines prevent, they do not cure

New Zealand

Travel bubble with Australia by April

Germany

https://www.dw.com/en/coronavirus-german-president-appeals-to-public-in-bitterly-serious-situation/a-55933631

President Frank-Walter Steinmeier

The situation is bitterly serious: 

thousands of deaths in a week and a rate of infection that is threatening to career out of control

 We cannot avoid restrictive measures

 The facts are unerring and they are distressing

Agreed by Merkel and state leaders from Wednesday

England, suicide rates

https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19roundup/2020-03-26#health 

July to September (3rd quarter registrations)

10.7 per 100,000 people

2017, UK, 10.1 deaths per 100,000

1,334 deaths registered 3rd quarter of 2020

Males, 16.3 suicide deaths per 100,000

Females, 5.4 suicide deaths per 100,000 

Similar to registrations in the same period in previous years

Risk factors for suicide

https://patient.info/doctor/suicide-risk-assessment-and-threats-of-suicide

Previous suicide attempt or previous self-harm

Male gender

Unemployment

Physical health problems such as pain

Living alone

Being unmarried

Alcohol and/or drug dependence

Active mental illness 

Protective factors, may include

A strong religious faith.

Family support to find alternative solutions to their problems.

Having children at home

A sense of responsibility for others

Problem-solving skills

